Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses.
about
Microparticles as mediators and biomarkers of rheumatic diseasePlatelet apoptosis in paediatric immune thrombocytopenia is ameliorated by intravenous immunoglobulin.Soluble TLT-1 modulates platelet-endothelial cell interactions and actin polymerization.Cellular microparticle and thrombogram phenotypes in the Prospective Observational Multicenter Major Trauma Transfusion (PROMMTT) study: correlation with coagulopathy.Levels of procoagulant microvesicles are elevated after traumatic injury and platelet microvesicles are negatively correlated with mortality.Procoagulant activity, but not number, of microparticles increases with age and in individuals after a single venous thromboembolism.Historical perspective and future directions in platelet research.Bench-to-bedside review: circulating microparticles--a new player in sepsis?Cross-sectional study of soluble selectins, fractions of circulating microparticles and their relationship to lung and skin involvement in systemic sclerosis.Increased atherothrombotic burden in patients with diabetes mellitus and acute coronary syndrome: a review of antiplatelet therapyEffects of anticoagulation on markers of activation of clotting following major orthopedic surgery.Intracranial hemorrhage: mechanisms of secondary brain injury.Microparticles: a critical component in the nexus between inflammation, immunity, and thrombosis.Microparticles and acute lung injury.Cell-derived microparticles in stored blood products: innocent-bystanders or effective mediators of post-transfusion reactions?Microparticles in health and disease.MRP1 and its role in anticancer drug resistance.Changes in the pattern of plasma extracellular vesicles after severe trauma.A Meta-Analysis of Circulating Microvesicles in Patients with Myocardial Infarction.Circulating microparticles, protein C, free protein S and endothelial vascular markers in children with sickle cell anaemia.Correlation and association between plasma platelet-, monocyte- and endothelial cell-derived microparticles in hypertensive patients with type 2 diabetes mellitus.A 32-month follow-up study of nanovesicle concentrations in blood from 12 patients with gastrointestinal stromal tumour treated with imatinib.Evaluation of microparticles in whole blood by multicolour flow cytometry assay.Expression of P-selectin (CD62P) on platelets after thrombin and ADP in hypotrophic and healthy, full-term newborns.Increased amounts of von Willebrand factor are bound to microparticles after infusion of desmopressin.Platelet-derived microparticles and platelet function profile in children with congenital heart disease.Circulating microparticles and plasma levels of soluble E- and P-selectins in patients with systemic sclerosis.PlA2 Polymorphism in Glycoprotein IIb/IIIa Modulates the Morphology and Nanomechanics of Platelets.Oat-enriched diet reduces inflammatory status assessed by circulating cell-derived microparticle concentrations in type 2 diabetes.Microparticles from β-thalassaemia/HbE patients induce endothelial cell dysfunction
P2860
Q27016054-38787524-D02E-47AA-84C6-E23D303658A7Q33398769-E9944037-D727-4B40-A834-B0ABB8397F73Q33917914-41CD3CBE-2C4A-4F84-92FE-30263AE1E227Q34160603-66704C32-677A-48BC-A0A8-AE682F8AF182Q34438775-991B7A77-DBDD-40E6-B67F-49110CB63B89Q34788985-08C53AB9-714B-4403-9B08-FF27DC5DCECAQ35185593-F67C341A-B070-4E58-82DD-D8700071DA06Q35559151-81C19B5A-6454-46A1-81D7-24BA62552AD7Q35743365-21E0C291-6A48-4C47-848E-B76A1992295CQ35755253-6FD92018-870E-4A4C-AC92-7CB5726CBE04Q36380166-8844F867-CBD9-48AB-8A46-EBF9A71AFA9FQ37897166-70EF6B2A-B0E5-4900-920E-E6FE442F9F86Q37922118-07C040E1-E223-4984-A770-2B4CDADFE4E0Q38021265-30EEF461-194F-4D34-A2CE-90023F58E408Q38034393-B684B0AC-1B42-44ED-B350-BA53BA21C237Q38118341-8620DE26-AA89-4441-ACE3-72F480B83FF3Q38626237-9C703BC6-F76D-4FE2-BA5E-ECD65227A9EBQ41512269-120F6910-A52E-4C6C-ADF3-AE2FF68AF38EQ41556597-FFA389B2-2594-45CC-B70F-4C3B8286D048Q43157080-410039FB-5751-43F3-A602-6E195B08F106Q43297937-D46332B8-EB23-44DC-91B6-B4C638D36539Q43455409-C89C31BE-63CC-4E8F-BE10-D1DFD1DC86FBQ44284893-A7FBFA1B-886C-42A1-B30D-9FB4406D3DCCQ44775804-7ED78406-B4FC-4F60-AA29-CDF4EC78C431Q45238676-37AF7959-1175-475C-8C51-D596CDFF8C61Q46094023-586FBB9E-1EB0-45F8-B500-F90217A86235Q46647964-F4E98E06-29FF-4A18-89D7-E540C06B727DQ51047838-14D7502D-303E-4DA4-94B1-C632C12F7B3EQ53063504-41A62AFE-0292-4D6E-90CB-50966B087FC8Q58695769-F81E1B35-06E2-4A56-BCEF-067D15EEB1EB
P2860
Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Platelet microparticles and va ...... atic and thrombotic responses.
@en
Platelet microparticles and va ...... atic and thrombotic responses.
@nl
type
label
Platelet microparticles and va ...... atic and thrombotic responses.
@en
Platelet microparticles and va ...... atic and thrombotic responses.
@nl
prefLabel
Platelet microparticles and va ...... atic and thrombotic responses.
@en
Platelet microparticles and va ...... atic and thrombotic responses.
@nl
P2093
P2860
P1433
P1476
Platelet microparticles and va ...... atic and thrombotic responses.
@en
P2093
Florence Toti
Jean-Marie Freyssinet
Nicolas Morel
Olivier Morel
P2860
P356
10.1080/09537100701817232
P577
2008-02-01T00:00:00Z